Peripheral brain-derived neurotrophic factor changes along treatment with extended release quetiapine during acute mood episodes: An open-label trial in drug-free patients with bipolar disorder

Andreazza, 2007, DNA damage in bipolar disorder, Psychiatry Research, 153, 27, 10.1016/j.psychres.2006.03.025 Andreazza, 2008, Oxidative stress markers in bipolar disorder: a meta-analysis, Journal of Affective Disorders, 111, 135, 10.1016/j.jad.2008.04.013 Autry, 2012, Brain-derived neurotrophic factor and neuropsychiatric disorders, Pharmacological Reviews, 64, 238, 10.1124/pr.111.005108 Berk, 2011, Does stage of illness impact treatment response in bipolar disorder? Empirical treatment data and their implication for the staging model and early intervention, Bipolar Disorders, 13, 87, 10.1111/j.1399-5618.2011.00889.x Berk, 2011, Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors, Neuroscience & Biobehavioral Reviews, 35, 804, 10.1016/j.neubiorev.2010.10.001 Chiesa, 2012, Quetiapine for bipolar depression: a systematic review and meta-analysis, International Clinical Psychopharmacology, 27, 76, 10.1097/YIC.0b013e32834e4c56 Conus, 2006, Symptomatic and functional outcome 12 months after a first episode of psychotic mania: barriers to recovery in a catchment area sample, Bipolar Disorders, 8, 221, 10.1111/j.1399-5618.2006.00315.x Duman, 2002, Synaptic plasticity and mood disorders, Molecular Psychiatry, 7, S29, 10.1038/sj.mp.4001016 Fernandes, 2011, Brain-derived neurotrophic factor as a state-marker of mood episodes in bipolar disorders: a systematic review and meta-regression analysis, Journal of Psychiatric Research, 45, 995, 10.1016/j.jpsychires.2011.03.002 First, 2002 Fumagalli, 2004, Quetiapine regulates FGF-2 and BDNF expression in the hippocampus of animals treated with MK-801, Neuroreport, 15, 2109, 10.1097/00001756-200409150-00022 Grande, 2010, The role of BDNF as a mediator of neuroplasticity in bipolar disorder, Psychiatry Investigation, 7, 243, 10.4306/pi.2010.7.4.243 Grande, 2012, Mediators of allostasis and systemic toxicity in bipolar disorder, Physiology & Behavior, 106, 46, 10.1016/j.physbeh.2011.10.029 Guy, 1976 Kapczinski, 2011, Peripheral biomarkers and illness activity in bipolar disorder, Journal of Psychiatric Research, 45, 156, 10.1016/j.jpsychires.2010.05.015 Karege, 2002, Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets, Neuroscience Letters, 328, 261, 10.1016/S0304-3940(02)00529-3 Kauer-Sant'Anna, 2009, Brain-derived neurotrophic factor and inflammatory markers in patients with early- vs. late-stage bipolar disorder, International Journal of Neuropsychopharmacology, 12, 447, 10.1017/S1461145708009310 Lang, 2007, Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity, Biological Psychiatry, 62, 530, 10.1016/j.biopsych.2007.01.002 López-Jaramillo, 2010, Effects of recurrence on the cognitive performance of patients with bipolar I disorder: implications for relapse prevention and treatment adherence, Bipolar Disorders, 12, 557, 10.1111/j.1399-5618.2010.00835.x Luo, 2005, Quetiapine reverses the suppression of hippocampal neurogenesis caused by repeated restraint stress, Brain Research, 1063, 32, 10.1016/j.brainres.2005.09.043 Magalhães, 2012, Illness burden and medical comorbidity in the systematic treatment enhancement program for bipolar disorder, Acta Psychiatrica Scandinavica, 125, 303, 10.1111/j.1600-0447.2011.01794.x Manji, 2012, Impaired mitochondrial function in psychiatric disorders, Nature Reviews. Neuroscience, 10.1038/nrn3229 McIntyre, 2007, A preclinical and clinical rationale for quetiapine in mood syndromes, Expert Opinion on Pharmacotherapy, 8, 1211, 10.1517/14656566.8.9.1211 Palomino, 2006, Decreased levels of plasma BDNF in first-episode schizophrenia and bipolar disorder patients, Schizophrenia Research, 86, 321, 10.1016/j.schres.2006.05.028 Park, 2006, Effects of quetiapine on the brain-derived neurotrophic factor expression in the hippocampus and neocortex of rats, Neuroscience Letters, 402, 25, 10.1016/j.neulet.2006.03.028 Post, 2007, Role of BDNF in bipolar and unipolar disorder: clinical and theoretical implications, Journal of Psychiatric Research, 41, 979, 10.1016/j.jpsychires.2006.09.009 Rosa, 2012, One-year psychosocial functioning in patients in the early vs. late stage of bipolar disorder, Acta Psychiatrica Scandinavica, 125, 335, 10.1111/j.1600-0447.2011.01830.x Schmidt, 2010, Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models, Neuropsychopharmacology, 35, 2378, 10.1038/npp.2010.114 Sole, 2012, Neurocognitive impairment across the bipolar spectrum, CNS Neuroscience & Therapeutics, 18, 194, 10.1111/j.1755-5949.2011.00262.x Tamayo, 2010, Level of response and safety of pharmacological monotherapy in the treatment of acute bipolar I disorder phases: a systematic review and meta-analysis, International Journal of Neuropsychopharmacology, 13, 813, 10.1017/S1461145709991246 Tohen, 2009, The International Society for Bipolar Disorders (ISBD) Task Force report on the nomenclature of course and outcome in bipolar disorders, Bipolar Disorders, 11, 453, 10.1111/j.1399-5618.2009.00726.x Torrent, 2011, Effects of atypical antipsychotics on neurocognition in euthymic bipolar patients, Comprehensive Psychiatry, 52, 613, 10.1016/j.comppsych.2010.12.009 Tramontina, 2009, Brain-derived neurotrophic factor serum levels before and after treatment for acute mania, Neuroscience Letters, 452, 111, 10.1016/j.neulet.2009.01.028 Vieta, 2005, Mood stabilization in the treatment of bipolar disorder: focus on quetiapine, Human Psychopharmacology: Clinical & Experimental, 20, 225, 10.1002/hup.689 Vieta, 2010, Treatment options for bipolar depression: a systematic review of randomized, controlled trials, Journal of Clinical Psychopharmacology, 30, 579, 10.1097/JCP.0b013e3181f15849 Willett, 1998, The design and analysis of longitudinal studies of development and psychopathology in context: statistical models and methodological recommendations, Development and Psychopathology, 10, 395, 10.1017/S0954579498001667 Williams, 1988, A structured interview guide for the Hamilton Depression Rating Scale, Archives of General Psychiatry, 45, 742, 10.1001/archpsyc.1988.01800320058007 Xu, 2006, Synergetic effects of quetiapine and venlafaxine in preventing the chronic restraint stress-induced decrease in cell proliferation and BDNF expression in rat hippocampus, Hippocampus, 16, 551, 10.1002/hipo.20184 Yatham, 2009, Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009, Bipolar Disorders, 11, 225, 10.1111/j.1399-5618.2009.00672.x Yoshimura, 2010, Adding a low dose atypical antipsychotic drug to an antidepressant induced a rapid increase of plasma brain-derived neurotrophic factor levels in patients with treatment-resistant depression, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 34, 308, 10.1016/j.pnpbp.2009.12.003 Yoshimura, 2007, Effects of paroxetine or milnacipran on serum brain-derived neurotrophic factor in depressed patients, Progress in Neuro-Psychopharmacology and Biological Psychiatry, 31, 1034, 10.1016/j.pnpbp.2007.03.001 Young, 1978, A rating scale for mania: reliability, validity and sensitivity, The British Journal of Psychiatry, 133, 429, 10.1192/bjp.133.5.429